Now it's a whole new ball game...
The CAR T market leaders come into play....bring on the license deals...Car T-Cell Therapy Market Leaders
- Novartis AG.
- Bristol-Myers Squibb Company.
- Johnson & Johnson.
- Sorrento Therapeutics, Inc.
- Gilead Sciences, Inc. ( Kite Pharma)
Big Pharma boardrooms "Your'e kidding aren't you, we can now access solid tumours with our CAR T's"
Big Pharma actuaries "We've just added 900% to our bottom line this year"
Opinions Only
Ann: FDA clears Imugene IND for onCARlytics first-in-class study, page-10
-
- There are more pages in this discussion • 139 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $757.1K | 13.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 2203877 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 244428 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |